| Literature DB >> 34343272 |
Jenifer Vallejo1, Clément Cochain2,3, Alma Zernecke2, Klaus Ley1,4.
Abstract
Immune cells in atherosclerosis include T, B, natural killer (NK) and NKT cells, macrophages, monocytes, dendritic cells (DCs), neutrophils, and mast cells. Advances in single-cell RNA sequencing (sRNA-Seq) have refined our understanding of immune cell subsets. Four recent studies have used scRNA-Seq of immune cells in human atherosclerotic lesions and peripheral blood mononuclear cells (PBMCs), some including cell surface phenotypes revealed by oligonucleotide-tagged antibodies, which confirmed known and identified new immune cell subsets and identified genes significantly up-regulated in PBMCs from HIV+ subjects with atherosclerosis compared to PBMCs from matched HIV+ subjects without atherosclerosis. The ability of scRNA-Seq to identify cell types is greatly augmented by adding cell surface phenotype using antibody sequencing. In this review, we summarize the latest data obtained by scRNA-Seq on plaques and human PBMCs in human subjects with atherosclerosis. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: Antibodies; Atherosclerosis; Human; Transcriptomes; scRNA-Seq
Mesh:
Year: 2021 PMID: 34343272 PMCID: PMC8921647 DOI: 10.1093/cvr/cvab260
Source DB: PubMed Journal: Cardiovasc Res ISSN: 0008-6363 Impact factor: 10.787